Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
01/2013
01/02/2013CN101247811B Quinoline derivatives as antibacterial agents
01/02/2013CN101229164B Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
01/02/2013CN101189222B Tri-, tetra-substituted-3-aminopyrrolidine derivative
01/02/2013CN101137349B Controlled release compositions for interferon based on PEGT/PBT block copolymers
01/02/2013CN101068926B Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
01/02/2013CN101035777B Modulators of hcv replication
01/01/2013US8344017 Anti-hepatitis C virus agents and anti-HIV agents
01/01/2013US8343988 Inhibitors of histone deacetylase
01/01/2013US8343981 Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents
01/01/2013US8343972 Organic compounds
01/01/2013US8343964 Indolic derivatives, their preparation processes and their uses in particular as antibacterials
01/01/2013US8343937 Methods and compositions for treating flaviviruses and pestiviruses
01/01/2013US8343913 Hsp90, buffering and drug resistance
01/01/2013US8343761 Methods of generating and using antibody-producing cells
01/01/2013US8343556 Composition for treating and/or preventing periodontal disease
01/01/2013US8343511 Methods and compositions for treating inflammatory bowel disease
01/01/2013US8343483 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
01/01/2013US8343477 Viricides; serine protease inhibitors
12/2012
12/27/2012WO2012178127A2 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
12/27/2012WO2012178078A2 Use of yscf, truncated yscf and yscf homologs as adjuvants
12/27/2012WO2012178036A2 Inhibitors of rtt109 as anti-fungal agents
12/27/2012WO2012177986A2 Conjugate-based antifungal and antibacterial prodrugs
12/27/2012WO2012177892A2 Type i interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis
12/27/2012WO2012177886A2 Process of forming crystals for use in a personal care composition
12/27/2012WO2012177756A2 Non-leaching antimicrobial wound dressing
12/27/2012WO2012177707A1 Phosphate esters of gyrase and topoisomerase inhibitors
12/27/2012WO2012177658A2 Methods of treating and preventing staphylococcus aureus infections and associated conditions
12/27/2012WO2012177635A1 Metalloenzyme inhibitor compounds
12/27/2012WO2012177075A2 Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections
12/27/2012WO2012177020A2 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
12/27/2012WO2012176909A1 Tripropeptin derivative or pharmacologically acceptable salt thereof, and antibacterial agent
12/27/2012WO2012176796A1 Method for amplifying nk cells
12/27/2012WO2012176582A1 Eye-drop-type vaccine for avian influenza
12/27/2012WO2012176149A1 Treatment of hepatitis c virus
12/27/2012WO2012175881A1 Topical film-forming composition, and use thereof for treating mycoses
12/27/2012WO2012175879A1 Film-forming composition, and use thereof for treating herpes
12/27/2012WO2012175733A1 Hcv combination therapy
12/27/2012WO2012175730A1 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof
12/27/2012WO2012175729A1 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof
12/27/2012WO2012175706A1 Use of 10h-benzo[g]pteridine-2,4-dione derivatives
12/27/2012WO2012175702A1 Rimfampicin analogue useful for infection imaging
12/27/2012WO2012175659A1 N-acetyl cysteine and composition thereof for use in the treatment of vaginal pathologies
12/27/2012WO2012175587A2 Novel crystalline cefoperazone intermediate
12/27/2012WO2012175581A1 Antiviral compounds
12/27/2012WO2012174784A1 Cefuroxime axetil tablet and direct all-powder compression method thereof
12/27/2012WO2012174730A1 Preparative method and use of zyj-d08a and its epimers as histone deacetylase inhibitors
12/27/2012WO2012174622A1 Plant extract obtained from kielmeyera aureovinosa which has antibiotic activity, isolated chemical compound, compositions comprising same, uses thereof and methods for preventing and treating bacterial infections
12/27/2012WO2012154122A3 A topical formulation for treatment of hyperkeratotic skin
12/27/2012WO2012150477A3 Medical uses of nanoclustered water
12/27/2012WO2012138911A3 Conjugates of anti-hiv drugs and somatostatin analogs
12/27/2012WO2012128508A3 Binding molecules capable of neutralizing the rabies virus, and uses thereof
12/27/2012WO2012128501A3 Pharmaceutical composition containing, as an active ingredient, m-3m3fbs, which is an activator of phospholipase c, for preventing or treating inflammatory diseases or infectious diseases
12/27/2012WO2012099507A3 Biopreparation balis for the prophylaxis and treatment of infectious diseases
12/27/2012WO2012093137A9 Liposome formulation suitable for treating or preventing tuberculosis
12/27/2012WO2012036437A9 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease
12/27/2012WO2011100838A9 Derivatives of l-plienyl-1.5-diliydio-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication
12/27/2012US20120331576 Pathogen Restriction Factors
12/27/2012US20120330019 Hepatitis C Virus Inhibitors
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329874 Synergetic composition comprising flavouring substances and organic acids and use thereof
12/27/2012US20120329871 Antimicrobial compounds
12/27/2012US20120329860 Uses of Beta-Nicotinamide Adenine Dinucleotide
12/27/2012US20120329857 Short Hairpin RNAs for Inhibition of Gene Expression
12/27/2012US20120329856 Methods And Compositions For Reducing Viral Genome Amounts In A Target Cell
12/27/2012US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
12/27/2012US20120329845 Pharmaceutical composition
12/27/2012US20120329842 Small molecule compounds as broad-spectrum inhibitors of metallo-beta-lactamases
12/27/2012US20120329827 Derivatives of pyridoxine for inhibiting hiv integrase
12/27/2012US20120329817 Mucosal bioadhesive slow release carrier for delivering active principles
12/27/2012US20120329815 Famciclovir for the Treatment of Recurrent Herpes Labialis using a One-Day Treatment
12/27/2012US20120329814 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
12/27/2012US20120329802 Metalloenzyme inhibitor compounds
12/27/2012US20120329797 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
12/27/2012US20120329790 Dentinal Drug Delivery Composition
12/27/2012US20120329782 Azepine inhibitors of janus kinases
12/27/2012US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments
12/27/2012US20120329770 Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
12/27/2012US20120329768 Process of forming crystals for use in a personal care composition
12/27/2012US20120329760 Rnase 7 as a marker for infection
12/27/2012US20120329758 Combined Treatment Utilizing VB-201
12/27/2012US20120329755 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
12/27/2012US20120329753 Chitosan-derivative compounds and methods of controlling microbial populations
12/27/2012US20120329746 Triazol compounds for treating biofilm formation
12/27/2012US20120329742 Use of antifungal compositions to treat upper gastrointestinal conditions
12/27/2012US20120329736 Treatment for gastrointestinal disorders using a selective, site-activated binding system
12/27/2012US20120329706 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
12/27/2012US20120329705 Compounds for proteasome enzyme inhibition
12/27/2012US20120329704 Process for the preparation of substituted prolyl peptides and similar peptidomimetics
12/27/2012US20120328720 Iridoid Based Formulations
12/27/2012US20120328718 Pharmaceutical compositions
12/27/2012US20120328711 Antimicrobial system for selective, site-activated binding at target sites
12/27/2012US20120328708 Disinfectant composition and its use in dental treatment
12/27/2012US20120328706 Polymer particle delivery compositions and methods of use
12/27/2012US20120328702 Nanoparticle compositions
12/27/2012US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor
12/27/2012US20120328693 Method for enhancing immune response in the treatment of infectious and malignant diseases
12/27/2012US20120328684 Citrobacter freundii antibacterial agents and their use
12/27/2012US20120328683 Alkylaminoalkyl oligomers as broad-spectrum antimicrobial agent
12/27/2012US20120328671 Composition
12/27/2012US20120328665 Composite nanoparticle, and preparation process and use thereof
1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 1798